U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Population Pharmacokinetics
  1. Regulatory Information

GUIDANCE DOCUMENT

Population Pharmacokinetics February 1999

Final

Population Pharmacokinetics

Issued by:
Guidance Issuing Office
Center for Drug Evaluation and Research
Center for Biologics Evaluation and Research

This guidance makes recommendations on the use of population pharmacokinetics in the drug development process to help identify differences in drug safety and efficacy among population subgroups. It summarizes scientific and regulatory issues that should be addressed using population pharmacokinetics. The guidance discusses when to perform a population pharmacokinetic study and/or analysis; how to design and execute a population pharmacokinetic study; how to handle and analyze population pharmacokinetic data; what model validation methods are available; and how to provide appropriate documentation for population pharmacokinetic reports intended for submission to the FDA. Although the information in this guidance for industry focuses on population pharmacokinetics, the principles discussed here are equally applicable to population pharmacodynamic and toxicokinetic studies.


Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Division of Dockets Management (HFA- 305)
Food and Drug Administration
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.